Enanta plans up to $75 million at-the-market stock offering via Jefferies

• Enanta set up an at-the-market equity program to sell up to USD 75 million of common stock through Jefferies.
• Proceeds plan centers on flexible, time-to-time share sales under its effective Form S-3 shelf registration.
• Jefferies will seek buyers based on company instructions; Enanta can pause or skip sales at any time.
• Jefferies commission can reach 3% of gross proceeds from any shares sold under the program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-294837), on July 02, 2026, and is solely responsible for the information contained therein.